T. Mastelić, V. Višić, T. Borovina Marasović, Žana Kralj, N. Rančić, D. Lasić
2026.1.8Medica Jadertina
tlooto Summary
Despite the scarce data, given the prevalence and the risks it carries, sarcopenia should not be omitted from the care of patients with schizophrenia.
Abstract
Research on sarcopenia in patients with schizophrenia is still in its infancy. The aim of our work was to review the literature on sarcopenia in people with schizophrenia. The literature was searched using the PubMed and Google scholar databases. Sarcopenia and schizophrenia share certain etiological processes and risk factors. People with schizophrenia have an increased risk of developing sarcopenia, as well as an increased prevalence of sarcopenia. As a screening tool for sarcopenia, the Ishii test is recommended, but the SARC-F can also be used. Bioelectrical impedance and dynamometer are used for diagnosis. Exercise, a protein-rich diet and protein supplements play a role in its prevention and treatment. Additional research is needed on common etiological processes and possible therapeutic interventions. Despite the scarce data, given the prevalence and the risks it carries, sarcopenia should not be omitted from the care of patients with schizophrenia.
Citation format
MASTELIĆ, T., et al. Sarcopenia in people with schizophrenia. Medica Jadertina, 2026, 55(3-4): 247–253.